Where does Gilgamesh Pharma's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Gilgamesh Pharma's 3 recorded funding rounds.

Premier Alternatives

Gilgamesh Pharma

New York, NY · Founded 2019 · Privately Held (backing)

Developer of novel chemical entities designed to transform the treatment of psychiatric disorders through rapid-acting and durable therapies. Gilgamesh Pharma is based in New York, NY and was founded in 2019. Its last reported valuation was $189 million in May 2022. It has raised $136 million across 3 recorded rounds; the latest was a $2.3 million seed round in Mar 2026.

Last reported valuation

$188.5M

Oct 2026

Priced at

—

Total raised

$135.8M

Last round

Seed Round

Mar 2026

Cap table — not yet on record

Gilgamesh Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Gilgamesh Pharma with a free account

·The complete investor list: 24 names
·Watch Gilgamesh Pharma: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Gilgamesh Pharma

Where does Gilgamesh Pharma's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Gilgamesh Pharma's 3 recorded funding rounds.